Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-␬b

Muscle wasting is often associated with chronic inflammation. Because tumor necrosis factor α (TNF‐α) has been implicated as a major mediator of cachexia, its effects on C2C12 myocytes were examined. TNF‐α activated nuclear factor‐κΒ (NF‐κΒ) and interfered with the expression of muscle proteins in differentiating myoblasts. Introduction of a mutant form of inhibitory protein κΒα (IκBα) restored myogenic differentiation in myoblasts treated with TNF‐α or interleukin 1β. Conversely, activation of NF‐KBby overexpression of IΚB kinase was sufficient to block myogenesis, illustrating the causal link between NF‐ΚB activation and inhibition of myogenic differentiation. The inhibitory effects of TNF‐α on myogenic differentiation were reversible, indicating that the effects of the cytokine were not due to nonspecific toxicity. Treatment of differentiated myotubes with TNF‐α did not result in a striking loss of muscle‐specific proteins, which shows that myogenesis was selectively affected in the myoblast stage by TNF‐α. An important finding was that NF‐ΚB was activated to the same extent in differentiating and differentiated cells, illustrating that once myocytes have differentiated they become refractory to the effects of NF‐ΚB activation. These results demonstrate that inflammatory cytokines may contribute to muscle wasting through the inhibition of myogenic differentiation via a NF‐κB‐dependent pathway.—Langen, R. C. J., Schols, A. M. W. J., Kelders, M. C. J. M., Wouters, E. F. M., Janssen‐Heininger, Y. M. W. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐KB. FASEB J. 15, 1169–1180 (2001)

[1]  C. Y. Wang,et al.  NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. , 2000, Science.

[2]  Y. E. Chin,et al.  Stat1 as a Component of Tumor Necrosis Factor Alpha Receptor 1-TRADD Signaling Complex To Inhibit NF-κB Activation , 2000, Molecular and Cellular Biology.

[3]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[4]  Michael Karin,et al.  The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation* , 1999, The Journal of Biological Chemistry.

[5]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[6]  G. Pavlath,et al.  Systemic administration of the NF-κB inhibitor curcumin stimulates muscle regeneration after traumatic injury. , 1999, American journal of physiology. Cell physiology.

[7]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[8]  M. Palacín,et al.  Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-κB and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[9]  S. Farmer,et al.  Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts. , 1999, Experimental cell research.

[10]  F. López‐Soriano,et al.  The role of cytokines in cancer cachexia , 1999, Medicinal research reviews.

[11]  A. Nagai,et al.  Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle cell injury directly in polymyositis. , 1999, Arthritis and rheumatism.

[12]  A. Giordano,et al.  TRAF2 expression in differentiated muscle , 1998, Journal of cellular biochemistry.

[13]  M. Spurlock,et al.  Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[14]  A. Miyajima,et al.  Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .

[16]  E. Duda,et al.  TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. , 1997, European journal of cell biology.

[17]  S. Matalon,et al.  Differential induction of c- fos, c- jun, and apoptosis in lung epithelial cells exposed to ROS or RNS. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[18]  H. Goebel,et al.  DNA‐fragmentation and expression of apoptosis‐related proteins in muscular dystrophies , 1997, Neuropathology and applied neurobiology.

[19]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[20]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[21]  H. Goebel,et al.  Apoptosis‐related Proteins in Skeletal Muscle Fibers of Spinal Muscular Atrophy , 1997, Journal of neuropathology and experimental neurology.

[22]  L. Zeng,et al.  Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. , 1997, International journal of cardiology.

[23]  A. Salminen,et al.  Down-regulation of transcription factors AP-1, Sp-1, and NF-kappa B precedes myocyte differentiation. , 1996, Biochemical and biophysical research communications.

[24]  E. Olson,et al.  Defining the regulatory networks for muscle development. , 1996, Current opinion in genetics & development.

[25]  T. Vary,et al.  Sepsis inhibits synthesis of myofibrillar and sarcoplasmic proteins: modulation by interleukin-1 receptor antagonist. , 1996, Shock.

[26]  M. Buck,et al.  Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. , 1996, The EMBO journal.

[27]  J. Nakashima,et al.  Tumor necrosis factor and coagulopathy in patients with prostate cancer. , 1995, Cancer research.

[28]  Z. Yablonka-Reuveni.  Development and postnatal regulation of adult myoblasts , 1995, Microscopy research and technique.

[29]  L. Bélec,et al.  Increased tumor necrosis factor-alpha serum levels in patients with HIV wasting syndrome and euthyroid sick syndrome. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[30]  T. Vary,et al.  Interleukin-1 receptor antagonist prevents sepsis-induced inhibition of protein synthesis. , 1994, The American journal of physiology.

[31]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[32]  N. Agell,et al.  Ubiquitin gene expression is increased in skeletal muscle of tumour‐bearing rats , 1994, FEBS letters.

[33]  M. Rudnicki,et al.  MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.

[34]  T. Braun,et al.  cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helix-loop-helix transcription factors Myf-5 and MyoD. , 1993, The Journal of biological chemistry.

[35]  Mike Rothe,et al.  Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor , 1993, Cell.

[36]  E. Olson,et al.  Interplay between proliferation and differentiation within the myogenic lineage. , 1992, Developmental biology.

[37]  R. Roubenoff,et al.  Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. , 1992, The Journal of rheumatology.

[38]  B. Löwenberg,et al.  Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis , 1992, European journal of clinical investigation.

[39]  P. Pekala,et al.  The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes. , 1990, The Journal of biological chemistry.

[40]  J. Wang,et al.  Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. , 1989, The American journal of clinical nutrition.

[41]  N. Anthonisen,et al.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.

[42]  K. Tracey,et al.  Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. , 1989, The American journal of physiology.

[43]  C. Scrimgeour,et al.  Muscle wasting in emphysema. , 1988, Clinical science.

[44]  Torti,et al.  Tumor necrosis factor inhibits human myogenesis in vitro , 1988, Molecular and cellular biology.

[45]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[46]  D. Yaffe,et al.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle , 1977, Nature.

[47]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[48]  E. Bernt,et al.  Creatine kinase in serum: 1. Determination of optimum reaction conditions. , 1976, Clinical chemistry.

[49]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[50]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.